600161.SH
天坛生物
SSE · Healthcare · Biotechnology · CN
CNY 11.94
−1.73%Margins
Gross margin
41.6%
EBITDA margin
38.3%
EBIT margin
27.6%
Net margin
16.2%
FCF margin
-0.4%
8.2%
Return on equity
5.8%
Return on assets
13.9%
Return on invested capital
0.36x
Asset turnover
CNY 624.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026